How can biosimilar companies attract the right talent? 20-Jul-2022 By Rachel Arthur Recruiting and nurturing talent will be incredibly important in the biosimilar industry as it continues its rapid evolution, according to RSA Talent Equity.
Automating cell and gene therapy manufacture ‘has to be accelerated’, says Lonza CEO 04-Nov-2019 By Ben Hargreaves Marc Funk explains how the company is ensuring it has the right people in place to move advanced therapies forward and into the future of manufacture.